Raiffeisen Bank International AG Acquires 14,762 Shares of Colgate-Palmolive Company $CL

Raiffeisen Bank International AG boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.4% in the third quarter, according to its most recent filing with the SEC. The firm owned 450,234 shares of the company’s stock after acquiring an additional 14,762 shares during the period. Raiffeisen Bank International AG owned 0.06% of Colgate-Palmolive worth $36,199,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Westside Investment Management Inc. increased its holdings in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the last quarter. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $29,000. Vermillion & White Wealth Management Group LLC grew its position in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares during the period. Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $30,000. Finally, MTM Investment Management LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the sale, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 184,683 shares of company stock valued at $17,486,693 over the last quarter. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of several recent analyst reports. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research note on Sunday, February 1st. Barclays boosted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Piper Sandler raised their price objective on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a report on Tuesday, December 9th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $100.00 price target on shares of Colgate-Palmolive in a report on Friday. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Trading Up 1.2%

CL opened at $95.07 on Friday. The stock has a market capitalization of $76.63 billion, a P/E ratio of 36.29, a P/E/G ratio of 4.24 and a beta of 0.29. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The firm’s fifty day simple moving average is $85.61 and its 200 day simple moving average is $82.27.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.